Fig. 1From: Radiomics for therapy-specific head and neck squamous cell carcinoma survival prognostication (part I)STARD Flowchart of patient inclusion into the study. The study cohort comprised 157 patients which were enrolled into the respective subgroups as depicted. RCTX, radiochemotherapyBack to article page